New York is suing four major chemical companies for decades of PFAS pollution that has contaminated the state’s drinking water and exposed residents to serious health risks. On July 9, 2026, New York Attorney General Letitia James filed a lawsuit against 3M, DuPont, The Chemours Co. Inc., and Corteva Inc., alleging they knowingly polluted the environment with “forever chemicals” while hiding the dangers from the public.
The lawsuit centers on PFAS—per- and polyfluoroalkyl substances—chemicals used in manufacturing that do not break down in the environment or the human body, and have been linked to cancer, birth defects, thyroid disease, and immune system damage. The contamination is not theoretical. PFAS has been detected in Long Island’s drinking water, affecting thousands of residents in one of the nation’s most densely populated regions. The companies allegedly possessed internal knowledge of PFAS risks decades before the public learned about the problem, yet continued operations and withheld critical safety information from regulators and consumers.
Table of Contents
- Which Chemical Companies Are Named in the New York PFAS Lawsuit?
- What Evidence Shows These Companies Knew About PFAS Dangers?
- What Health Risks Are Associated With PFAS Contamination?
- What Compensation and Relief Is New York Seeking?
- How Do Settlements in PFAS Cases Actually Work?
- Why Does the 1981 DuPont Pregnant Workers Incident Matter to This Lawsuit?
- What Is the Timeline for This Lawsuit and What Should Affected Residents Know?
Which Chemical Companies Are Named in the New York PFAS Lawsuit?
The defendants in the lawsuit are 3M, DuPont, Chemours, and Corteva. These are not minor players. 3M manufactures Scotchgard and countless industrial products. DuPont and Chemours (which spun off from DuPont) produced Teflon and perfluorinated chemicals. Corteva is a major agrochemical company.
Together, they have significant historical involvement in PFAS production and distribution. The lawsuit alleges these companies are responsible for contaminating New York’s environment and drinking water supplies through decades of manufacturing, use, and disposal of PFAS-containing products without adequate safeguards. The companies have substantial resources and legal experience defending product liability claims. However, they now face a state attorney general with the power to pursue public nuisance claims, as well as separate actions from individual consumers and municipalities. The scope of the PFAS pollution reaches beyond any single factory or facility—the chemicals have migrated through groundwater, surface water, and municipal water systems across the state.
What Evidence Shows These Companies Knew About PFAS Dangers?
The lawsuit alleges that 3M scientists detected PFAS in employee blood as early as the 1970s, decades before public health agencies identified PFAS as a widespread contaminant. This internal knowledge was not disclosed. The company reportedly tracked PFAS in its own workers but did not inform them of the risks or take public action to warn about contamination. This pattern of internal awareness coupled with external silence is central to the state’s allegations of fraud and negligence.
An even more serious incident allegedly occurred in 1981, when DuPont secretly monitored 50 female employees who had been exposed to PFAS, including 7 pregnant workers. According to the lawsuit, 2 of the babies born to these exposed employees had birth defects. Despite this evidence linking PFAS exposure to birth defects in humans, DuPont did not inform the affected employees, regulators, or the public. This concealment—particularly regarding risks to pregnancy and fetal development—forms part of the legal claim that the companies acted with knowledge of harm while keeping that knowledge hidden.
What Health Risks Are Associated With PFAS Contamination?
PFAS exposure has been linked to multiple serious health conditions. Cancer is the most widely publicized concern, with studies indicating elevated risks of kidney and testicular cancer among people with elevated PFAS blood levels. Birth defects represent another major concern, particularly following the alleged 1981 incident involving DuPont employees. Thyroid disease, immune system suppression, high cholesterol, and liver damage have also been documented in scientific research on PFAS-exposed populations.
Long Island residents drinking contaminated water face these risks without their knowledge or the ability to fully protect themselves through household filtration. Unlike some contaminants that can be filtered with activated carbon or removed through reverse osmosis, PFAS chemicals are particularly difficult to eliminate with standard home water treatment methods. Many families have relied on municipal water systems that were not screening for PFAS until recently, meaning years of potential exposure without awareness. The health effects also have long latency periods—some related to PFAS exposure may not appear for years or decades.
What Compensation and Relief Is New York Seeking?
New York is seeking multiple forms of relief. The lawsuit demands funding for cleanup of contaminated drinking water sources, medical monitoring programs for affected residents, and damages for the costs already incurred by municipalities to treat or replace contaminated water supplies. The state also seeks penalties that would require the companies to properly warn consumers about PFAS-related health risks going forward, preventing continued exposure through misinformation or product mislabeling. A prior settlement provides some guidance on scale.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
In May 2025, 3M agreed to pay New Jersey $450 million over 25 years to resolve PFAS drinking water contamination claims. While that settlement addressed one state and specific water district impacts, the New York lawsuit encompasses a larger population and potentially broader contamination. The scale of relief sought in New York may exceed the New Jersey precedent, given that Long Island alone serves millions of residents. However, the New Jersey example also shows that these cases typically result in payments spread over decades rather than lump sums, and the amounts may not fully cover all cleanup and health monitoring costs.
How Do Settlements in PFAS Cases Actually Work?
PFAS lawsuits typically follow a pattern established in earlier contamination cases, but with significant uncertainty due to the novelty of PFAS litigation. Settlements often include a combination of payments into a fund for remediation, medical monitoring programs where affected residents can have their PFAS blood levels tested and receive health screenings, and funding for water system improvements or replacement. Some settlements also include money for natural resource damages, since PFAS contamination affects not just drinking water but also ecosystems and agricultural land.
One limitation to understand: even large settlements do not always result in complete remediation. The New Jersey settlement, while substantial, funds water treatment improvements over 25 years, meaning affected communities will continue dealing with the contamination during the entire payout period. Additionally, PFAS is a global problem—settlement with one set of companies in one state does not address the broader contamination already in the environment or prevent new PFAS releases from other sources. Some municipalities have had to invest their own funds to accelerate cleanup while waiting for settlement payments to materialize.
Why Does the 1981 DuPont Pregnant Workers Incident Matter to This Lawsuit?
The 1981 incident involving DuPont’s monitoring of pregnant employees is significant because it demonstrates knowledge of human health effects at a specific, vulnerable population. If DuPont observed birth defects in babies born to exposed pregnant workers and chose not to disclose this information, it strengthens allegations that the company knowingly concealed risks. This is not a case where the company could claim it was unaware of dangers—there is alleged documentary evidence of the company investigating and observing adverse outcomes in real people.
Courts and juries view corporate conduct that conceals known hazards from pregnant women and their unborn children with particular severity. This incident, if proven, goes beyond negligence to suggest intentional fraud or reckless disregard for public safety. The allegation is not that PFAS exposure accidentally caused birth defects in employees’ children, but that DuPont knew this was happening and kept quiet about it.
What Is the Timeline for This Lawsuit and What Should Affected Residents Know?
The lawsuit was filed on July 9, 2026, meaning it is in early stages. PFAS litigation typically takes several years to resolve, whether through settlement or trial. Discovery—the phase where both sides exchange documents and evidence—will likely consume 18 to 36 months. Given that similar environmental contamination cases have settled, and given the existence of the New Jersey precedent, a settlement negotiation may begin within 2 to 3 years of filing.
Residents in affected areas should not wait for a lawsuit outcome to address potential PFAS exposure. Testing of personal blood PFAS levels is available through some healthcare providers and medical monitoring programs. Certain water filtration systems have been shown to reduce PFAS in drinking water, though no household filter eliminates all PFAS entirely. Some residents have switched to bottled water or installed whole-house carbon filters, though these approaches have cost and environmental trade-offs. Documentation of water testing results, medical diagnoses, and water treatment expenses may be relevant if an individual claim process is established as part of a settlement.
You Might Also Like
- New York pursues sweeping lawsuit against chemical manufacturers for water pollution
- New York Legal Action: Chemical Industry Faces PFAS Contamination Liability Claims
- Manufacturers face multi-state lawsuit alleging decades of water contamination damage